insights_auto
Outlook: 50.0% bullish·11.5% bearish
Go to analysischevron_right
CVSH34:BVMF
Cvs Health Corporation BDR
R$46.69
arrow_upward
+1.24%(+0.57) 1D
Nov 9, 5:30:56 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CVSH34...
Open
R$46.81
High
R$46.81
Low
R$46.69
Mkt. cap
109.08B
Avg. vol.
346.00
Volume
316.00
52-wk high
R$57.82
52-wk low
R$36.22
Shares outstanding
1.28B
No. of employees
260K
Open
R$46.81
High
R$46.81
Low
R$46.69
Mkt. cap
109.08B
Avg. vol.
346.00
Volume
316.00
52-wk high
R$57.82
52-wk low
R$36.22
Shares outstanding
1.28B
No. of employees
260K
News stories
From web sources and news partners
Investing.com Canada
·
8 hours ago
CVS Health at Wolfe conference: split aims to unlock growth By Investing.com
San Juan Daily Star
·
11 hours ago
CVS to split off drugstore business, ending its bigger-is-better era
Big News Network.com
·
19 hours ago
CVS to split $117 billion healthcare business into two companies
Bloomberg.com
·
23 hours ago
Watch CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.
On November 4, 2026, CVS announced that they will split into two companies, making it the largest split in the healthcare business. Wikipedia
About Cvs Health Corporation BDR
CEODavid Joyner
Employees260K
Founded1963
HeadquartersWoonsocket, Rhode Island, United States
SectorHealth Care
IndustryHealth care provider
Websitecvshealth.com
Last report
Nov 4, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$2.09 / $1.65
+26.60%beat
arrow_upward
Revenue / Est. (USD)
107.75B / 104.69B
+2.92%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 105.10B | 99.85B | 105.46B | 107.75B |
Cost of goods sold | 92.13B | 84.80B | 90.35B | 93.50B |
Cost of revenue | 92.13B | 84.80B | 90.35B | 93.50B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 11.32B | 10.93B | 11.04B | 11.32B |
Operating expense | 11.32B | 10.93B | 11.04B | 11.32B |
Total operating expenses | 103.45B | 95.73B | 101.38B | 104.82B |
Operating income | 1.65B | 4.12B | 4.07B | 2.93B |
Other non operating income | -88.00M | 32.00M | 31.00M | 30.00M |
EBT including unusual items | 1.35B | 3.94B | 3.98B | 2.85B |
EBT excluding unusual items | 1.37B | 3.95B | 3.99B | 2.86B |
Income tax expense | -1.57B | 981.00M | 982.00M | 678.00M |
Effective tax rate | -115.88% | 24.91% | 24.69% | 23.80% |
Other operating expenses | - | - | - | - |
Net income | 2.94B | 2.94B | 2.98B | 2.17B |
Net profit margin | 2.80% | 2.95% | 2.82% | 2.02% |
Earnings per share | 1.09 | 2.57 | 2.58 | 2.09 |
Interest and investment income | 594.00M | 574.00M | 641.00M | 647.00M |
Interest expense | -787.00M | -774.00M | -757.00M | -747.00M |
Net interest expenses | -193.00M | -200.00M | -116.00M | -100.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 2.80B | 5.23B | 5.20B | 4.06B |
Gain or loss from assets sale | - | - | - | - |
Upcoming events